Literature DB >> 25070521

[Aerodigestive fistula formation in antiangiogenic tyrosine kinase inhibitor therapy].

K Lorenz1, H Dralle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25070521     DOI： 10.1007/s00104-014-2842-7

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  2 in total

1.  Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.

Authors:  Marcia S Brose; Christopher M Nutting; Barbara Jarzab; Rossella Elisei; Salvatore Siena; Lars Bastholt; Christelle de la Fouchardiere; Furio Pacini; Ralf Paschke; Young Kee Shong; Steven I Sherman; Johannes W A Smit; John Chung; Christian Kappeler; Carol Peña; István Molnár; Martin J Schlumberger
Journal:  Lancet       Date:  2014-04-24       Impact factor: 79.321

2.  Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.

Authors:  Ramona Dadu; Steven G Waguespack; Steven I Sherman; Mimi I Hu; Naifa L Busaidy; Camilo Jimenez; Mohammed A Habra; Anita K Ying; Roland L Bassett; Maria E Cabanillas
Journal:  Oncologist       Date:  2014-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.